Copyright © 2008 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 82, Issue 4, 992-1002, 03 April 2008
doi:10.1016/j.ajhg.2008.03.004
Article
Sylvain Hanein1, 2, 14, 15, Elodie Martin1, 2, 15, Amir Boukhris1, 2, 3, 4, Paula Byrne5, Cyril Goizet1, 2, 6, Abdelmadjid Hamri7, Ali Benomar8, Alexander Lossos9, Paola Denora1, 2, 10, José Fernandez1, 2, Nizar Elleuch4, Sylvie Forlani1, 2, Alexandra Durr1, 2, 3, Imed Feki4, Michael Hutchinson11, Filippo M. Santorelli10, Chokri Mhiri4, Alexis Brice1, 2, 3, 12, 13 and Giovanni Stevanin1, 2, 3,
, 
1 Institut National de la Santé et de la Recherche Médicale (INSERM), Unité Mixte de Recherche (UMR) S679, Neurologie et Thérapeutique Expérimentale, Paris, F-75013 France
2 Université Pierre et Marie Curie (UPMC), UMR S679, Paris F-75013, France
3 Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique et Cytogénétique, Paris 75013, France
4 Service de Neurologie, Hôpital Universitaire Habib Bourguiba, 3029 Sfax, Tunisia
5 School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College, Belfield, Dublin 4, Ireland
6 Laboratoire de Génétique Humaine, Université Victor Segalen Bordeaux 2, Service de Génétique Médicale, Hôpital Pellegrin, Bordeaux 33076, France
7 Hôpital Benbadis, 25000 Constantine, Algeria
8 Départements de Neurologie B et Neurogénétique, Hôpital des Spécialités, BP 6402 Rabat, Morocco
9 Department of Neurology, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem, Israel
10 Unit of Molecular Medicine, IRCCS-Bambino Gesù Children's Hospital, 4-00165 Rome, Italy
11 Department of Neurology, St Vincent's University Hospital, University College, Belfield, Dublin 4, Ireland
12 AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Fédération de Neurologie, Paris 75013 France
13 Université Pierre et Marie Curie, Faculté de Médecine Pitié-Salpêtrière, Paris F-75013 France
Corresponding authorAbstract
Hereditary spastic paraplegias (HSPs) are genetically and phenotypically heterogeneous disorders. Both “uncomplicated” and “complicated” forms have been described with various modes of inheritance. Sixteen loci for autosomal-recessive “complicated” HSP have been mapped. The SPG15 locus was first reported to account for a rare form of spastic paraplegia variably associated with mental impairment, pigmented maculopathy, dysarthria, cerebellar signs, and distal amyotrophy, sometimes designated as Kjellin syndrome. Here, we report the refinement of SPG15 to a 2.64 Mb genetic interval on chromosome 14q23.3-q24.2 and the identification of ZFYVE26, which encodes a zinc-finger protein with a FYVE domain that we named spastizin, as the cause of SPG15. Six different truncating mutations were found to segregate with the disease in eight families with a phenotype that included variable clinical features of Kjellin syndrome. ZFYVE26 mRNA was widely distributed in human tissues, as well as in rat embryos, suggesting a possible role of this gene during embryonic development. In the adult rodent brain, its expression profile closely resembled that of SPG11, another gene responsible for complicated HSP. In cultured cells, spastizin colocalized partially with markers of endoplasmic reticulum and endosomes, suggesting a role in intracellular trafficking.
| ZFYVE27 (SPG33), a Novel Spastin-Binding Protein, Is Mutated in Hereditary Spastic Paraplegia The American Journal of Human Genetics, Volume 79, Issue 2, 1 August 2006, Pages 351-357 Ashraf U. Mannan, Philip Krawen, Simone M. Sauter, Johann Boehm, Agnieszka Chronowska, Walter Paulus, Juergen Neesen and Wolfgang Engel Abstract Spastin, the most commonly mutated protein in the autosomal dominant form of hereditary spastic paraplegia (AD-HSP) has been suggested to be involved in vesicular cargo trafficking; however, a comprehensive function of spastin has not yet been elucidated. To characterize the molecular function of spastin, we used the yeast two-hybrid approach to identify new interacting partners of spastin. Here, we report ZFYVE27, a novel member of the FYVE-finger family of proteins, as a specific spastin-binding protein, and we validate the interaction by both in vivo coimmunoprecipitation and colocalization experiments in mammalian cells. More importantly, we report a German family with AD-HSP in which ZFYVE27 (SPG33) is mutated; furthermore, we demonstrate that the mutated ZFYVE27 protein shows an aberrant intracellular pattern in its tubular structure and that its interaction with spastin is severely affected. We postulate that this specific mutation in ZFYVE27 affects neuronal intracellular trafficking in the corticospinal tract, which is consistent with the pathology of HSP. Abstract | | |